Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating MutationsSeiji Yano, Saburo Sone, Wei Wang et al.|Cancer Research|2008Cited by 642
Follistatin Suppresses the Production of Experimental Multiple-Organ Metastasis by Small Cell Lung Cancer Cells in Natural Killer Cell–Depleted SCID MiceHirokazu Ogino, Saburo Sone, Hiromu Sugino et al.|Clinical Cancer Research|2008Cited by 83
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumabAtsushi Mitsuhashi, Yasuhiko Nishioka, Hisanori Uehara et al.|Nature Communications|2015Cited by 80
E7080, a Multi–Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production ProfilesKenji Ikuta, Saburo Sone, Seiji Yano et al.|Clinical Cancer Research|2009Cited by 72
Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangementHirokazu Ogino, Saburo Sone, Masaki Hanibuchi et al.|Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University)|2009Cited by 23